Stay updated with breaking news from Clover biopharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bivalent SCB-1019 significantly boosted RSV-A and RSV-B neutralization titers to approximately 6,600 IU/mL and approximately 46,000 IU/mL , respectively Preliminary Phase I data in target. ....
Clover Announces Positive Phase Ⅰ Results for SCB-219M for Treatment of Chemotherapy-Induced Thrombocytopenia (CIT) streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Clover Initiates Phase Ⅰ Clinical Trial for RSV Vaccine Candidate streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Clover Completes BLA Submission for Seasonal Influenza Vaccine in Brazil streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Unofficial sources said Joincare would seek to raise around $300 to $400 million. Click here to read a weekly update on China biopharma companies. ....